argenx Agrees to Acquire Unnatural Products

Company argenx; Unnatural Products (UNP) Event Type Acquisition ($550 million upfront; up to $595 million contingent) Modality Macrocyclic peptides Asset UNP macrocycle discovery platform Target Not disclosed Disease Area Immunology Summary Recovered source-gap item: on November 9, argenx announced an agreement to acquire the remaining…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *